SCHEMBL132175

SCHEMBL132175

O=C(O)c1ccc(Cl)cc1O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.69
CA2 P00918 2/20 0.69
TSHR P16473 3/20 0.65
CASP1 P29466 1/20 0.65
SMN1; SMN2 Q16637 1/20 0.65
ALDH1A1 P00352 7/20 0.61
CA12 O43570 1/20 0.61
CA7 P43166 1/20 0.61
CA9 Q16790 1/20 0.61
CA14 Q9ULX7 1/20 0.61
TP53 P04637 1/20 0.59
KDM4E B2RXH2 4/20 0.57
MAPT P10636 2/20 0.57
CYP3A4 P08684 2/20 0.57
PTPN1 P18031 2/20 0.57
GAA P10253 1/20 0.57
ESR2 Q92731 1/20 0.57
HSD17B10 Q99714 5/20 0.54
HPGD P15428 4/20 0.54
PYGL P06737 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7085459 0.98 CA1 (0.67) CA1CA2TSHRCASP1SMN1; SMN2
Formic Acid SCHEMBL28747374 0.92 CA1 (0.60) CA1CA2TSHRCASP1SMN1; SMN2
Salicylic Acid SCHEMBL5670430 0.90 ALDH1A1 (0.67) CA1CA2TSHRCASP1SMN1; SMN2
SCHEMBL27612735 0.84 CA1 (0.54) CA1CA2TSHRCASP1SMN1; SMN2
Tetraethylene Glycol SCHEMBL11023844 0.83 CA1 (0.50) CA1CA2TSHRCASP1SMN1; SMN2
5-Chlorosalicylic Acid SCHEMBL29499764 0.82 CA1 (1.00) CA1CA2TSHRCASP1SMN1; SMN2
SCHEMBL4880939 0.82 CA1 (0.52) CA1CA2TSHRCASP1SMN1; SMN2
5-Chlorosalicylic Acid SCHEMBL130605 0.82 CA1 (1.00) CA1CA2TSHRCASP1SMN1; SMN2
SCHEMBL1000440 0.81 ALDH1A1 (0.71) CA1CA2TSHRCASP1SMN1; SMN2
5-Chlorosalicylic Acid SCHEMBL943143 0.80 CA1 (0.96) CA1CA2TSHRCASP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1083 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12630503-B2 Method for producing benzopyranone compound and novel intermediate used therein ILAB (KR) 2026-05-19 US claimed
EP-4661890-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS Purdue Research Foundation (US) 2025-12-17 EP claimed
US-20250214921-A1 METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND KAO CORPORATION (JP) 2025-07-03 US claimed
EP-4501896-A1 METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND Kao Corporation (JP) 2025-02-05 EP claimed
CN-118973990-A Process for producing cyclic diketone compound 花王株式会社 2024-11-15 CN claimed
WO-2024185393-A1 HIGHLY POLARIZED OBJECT, METHOD FOR PRODUCING SAME, HIGH POLARIZATION METHOD, AND HIGH POLARIZATION DEVICE 国立大学法人徳島大学 2024-09-12 WO claimed
WO-2024167565-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS PURDUE RESEARCH FOUNDATION (US) 2024-08-15 WO claimed
CN-115427385-B Process for producing benzopyrone compound and novel intermediate therefor 艾伊莱布 2024-03-01 CN claimed
CN-115722210-B Recursive nanofiber-based detection material and preparation method and application thereof 广西大学 2024-02-20 CN claimed
WO-2023189722-A1 METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND 花王株式会社 2023-10-05 WO claimed
EP-1206524-A2 METHODS FOR GENERATING DOUBLED HAPLOID PLANTS Northwest Plant Breeding Co. (US) 2002-05-22 EP claimed
US-6362393-B1 Methods for generating doubled haploid plants NORTHWEST PLANT BREEDING COMPANY 2002-03-26 US claimed
US-6294186-B1 Antimicrobial compositions comprising a benzoic acid analog and a metal salt PROCTER & GAMBLE COMPANY, THR 2001-09-25 US claimed
EP-1112347-A1 METHODS FOR GENERATING DOUBLED HAPLOID PLANTS Northwest Plant Breeding Co. (US) 2001-07-04 EP claimed
WO-2001014518-A2 METHODS FOR GENERATING DOUBLED HAPLOID PLANTS NORTHWEST PLANT BREEDING CO. (US) 2001-03-01 WO claimed
EP-1018927-A1 LIGHTING ELEMENT FOR VISUAL OR PHOTOGRAPHIC MEDICAL EXAMINATION Laboratoires Piette International S.A. (BE) 2000-07-19 EP claimed
WO-2000014202-A1 METHODS FOR GENERATING DOUBLED HAPLOID PLANTS NORTHWEST PLANT BREEDING COMPANY (US) 2000-03-16 WO claimed
WO-1999016342-A1 LIGHTING ELEMENT FOR VISUAL OR PHOTOGRAPHIC MEDICAL EXAMINATION LABORATOIRES PIETTE INTERNATIONAL S.A. (BE) 1999-04-08 WO claimed
US-5821385-A REACTING 2,4-DICHLOROBENZOIC ACID WITH GLYCINE AND A BASE IN WATER WITH HEAT IN THE PRESENCE OF COPPER AND OXYGEN UNDER BASIC CONDITIONS HOECHST AKTIENGESELLSCHAFT (DE) 1998-10-13 US claimed
US-4374671-A CONTAINING ZINC OXIDE, A SALICYCLIC ACID AND A METAL SISLICATE FUJI PHOTO FILM CO.LTD. (JP) 1983-02-22 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12630503-B2 Method for producing benzopyranone compound and novel intermediate used therein TNF, NFKBIA, TNFRSF1A CA1 3441/4885CA2 2768/4885TSHR 1818/4885
US-20250214921-A1 METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND HSD17B7, HSD17B12, BCKDK CA1 2942/4885CA2 3272/4885TSHR 4605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.